Embed Size (px)
Citation preview
Making Personalized Medicine Accessible and
Affordable
95% of people have genetic variations affecting drug response
Finding the right medication in the right dosage is costly, time consuming and can be very dangerous
Everyone responds differently to medications
1
Your lifetime medication guide
Pillcheck Report is Updated as More Evidence Becomes Available
Pillcheck covers 70% of all prescribed medications…and growing
Results can be used now and in the future as your medication needs change
2
Pillcheck value
Save time, money
Minimize side effects
Feel better, sooner
3
1. Establish budget & define eligibility criteria
2. Promote to plan members
1. Send cheek swab sample in prepaid envelope
2. Fill in online medication form3. Share results with healthcare providers
Health & Life Benefits Plan sponsor
Pillcheck is marketed through insurance, benefit plans and pharmacists
End-consumer, plan member
Business model
4
● Active 39 year old
● Jogs
● Plays tennis on weekends
● Has rarely taken any medications
Kevin
5
● Recently, twisted an ankle while at work
● Prescribed Tylenol3, a common painkiller containing codeine, but it’s not working well
● Orders Pillcheck through his company health benefit plan
Kevin
6
78
Risk
Methadone CodeineFentanyl
HydrocodoneHydromorphone
KetamineMorphine
CelecoxibDiclofenac
FlurbiprofenPiroxicam
Analgesics
TREATMENT AREA
EsomeprazoleLansoprazoleOmeprazolePantoprazole
DexlansoprazoleRabeprazole
Gastroenterology
Kevin’s Resultswww.pillcheck.com
$499
Summary of Your Test
USE WITH CAUTION
MORE FREQUENTMONITORING
USE WITH INCREASEDCAUTION
CONSIDER ALTERNATIVES
USE AS DIRECTED
STANDARD PRECAUTION
a pharmacogenetic variant cannot be eliminated, only a change in treatment can potentially prevent adverse events.
HEALTH SERVICES
Federal Agency, Canada
HEALTH and LIFE BENEFITS
Global re-insurance company
Our clients and partners
8
Large Market Opportunity
$3B Addressable Canadian Market
6.9MMCanadians are
covered by Insuranceand take Pillcheck
prescriptions
9
275MMindividuals in
North America, Europe take medications
from the Pillcheck list
Revenue Model
50% Gross Margin
● Platform License, by Region & by Enterprise
Future add-on sales:● Nutrition Genomics● Data analysis of the tested
cohort for enterprise clients
10
Accelerated growth during the past 12 months
Diverse data sets drive GeneYouIn analytics program
Revenue 2019
$550k
Signed partners reach
10.5MMindividuals in Canada
11
Raising $5MM
Key account mgmt, marketing to 10+ million lives with signed partners in Canadian benefits
Worker’s comp insurers: USA
Following launch in Denmark in 2018, enter UAE
Product & analytics in Life Insurance
01
020304
12
Pillcheck helps people avoid prescriptions that do not work with their genetics, and the time and resources wasted to correct them. www.pillcheck.com/investors
Veronika Litinski
CEO, GeneYouIn Inc
M: 647 309 9043
❏ $110 billion addressable market serving 275 million people who take Pillcheck-covered medications
❏ Commercial in Canada and Scandinavia
❏ Signed clients reach 40% of Canadian private benefits market
Raising $5MM
13
